shutterstock_1852862020
Shutterstock_1852862020
15 August 2022Reinsurance

Compre expands legacy MedMal business


Compre has acquired the hospital liability portfolio of German insurer Basler Sachversicherungs-AG, an entity of the Baloise Group, subject to regulatory approval by the German Federal Financial Supervisory Authority. Terms of the transaction are not disclosed.

The deal, structured as a portfolio transfer, is the latest step in its ambition to build a centre of excellence for legacy MedMal business in Europe. The portfolio mainly consists of underwriting years 2004 to 2018 and as such has been in run-off for several years. The transaction, which is expected to close by year end 2022, includes the hospital liability portfolio of Basler with technical liabilities of approximately €200 million.

Subject to the relevant regulatory approvals, the portfolio will transfer in its entirety to Compre’s Finnish subsidiary Bothnia International Insurance Company. Compre will work closely with Detmold-based Ecclesia Group Assekuranz Service GmbH, which will continue to provide claims support for existing customers, ensuring smooth continuity of service for policyholders.

In addition, Compre also recently completed a two-tranche loss portfolio transfer (LPT) for an undisclosed European insurer, with the second tranche covering unexpired risks on a pre-determined basis. This is the first time Compre has underwritten a two-tranche LPT and is developing its pre-packaged forward LPT proposition to deliver additional future income, while providing greater certainty for its clients’ future results.

Simon Hawkins, chief executive Europe said: “This transaction also demonstrates, after Compre recently redomiciled to Bermuda, our commitment to executing legacy deals in Europe as well as the Lloyd’s and US legacy markets. While this is a new class of business for Compre, it is very much a signal of our intent to build MedMal into a significant additional area of specialisation.”


More on this story

Medical
25 August 2022   Deal structured as loss portfolio transfer.

More on this story

Medical
25 August 2022   Deal structured as loss portfolio transfer.